GlassScriptPhysician profile
George C Papachristou
NPI 1003077975
$6,097.72
in general payments reported to CMS, 2019-2025
10 companies · $317 in 2025
The $317 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $49.45 · 2021: $98.26 · 2022: $99.84 · 2023: $19.25 · 2024: $5,514 · 2025: $317.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $5,418 · Food and Beverage: $432.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $5,418.48 |
| Food and Beverage | $431.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec Digital Innovations LLC | $5,418.48 | 2024 | Veracity Surgical |
| Abbvie INC. | $225.09 | 2025 | |
| Carl Zeiss Meditec USA, INC. | $99.84 | 2022 | |
| New World Medical,INC. | $98.26 | 2021 | |
| Glaukos Corporation | $79.28 | 2024 | Idose |
| Alcon Vision LLC | $53.54 | 2025 | Hydrus Microstent |
| Allergan, INC. | $49.45 | 2020 | |
| Tarsus Pharmaceuticals, INC. | $38.54 | 2025 | Xdemvy |
| Carl Zeiss Meditec Cataract Technology INC. | $19.25 | 2023 | |
| Bausch & Lomb Americas INC. | $15.99 | 2024 | Envista Mx60 Iol, Totalvisc |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Papachristou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.